Absence of COVID-19 Infection in Patients Accessing IBD Unit at Humanitas, Milan: Implications for Postlockdown Measures.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 32852334.
- Also identified by DOI 10.14309/ajg.0000000000000829 and PMC identifier 7499879.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The risk of coronavirus disease-19 infection for healthcare professionals and patients in hospitals remains unclear. We investigated whether precautions adopted in our inflammatory bowel disease (IBD) unit have minimized the risks of infection for all patients accessing our facilities in a 1-month period by assessing the rate of coronavirus disease-19 infection in the follow-up period. Three hundred-twenty patients with IBD were included. None were infected from severe acute respiratory syndrome-coronavirus 2 in the follow-up period. None of the IBD team members were infected. Neither pharmacological immunosuppression nor access to the hospital seem to be risk factors for infection in patients with IBD.
Medical subject headings
- Coronavirus Infections
- Hospital Units
- Immunosuppressive Agents
- Infection Control
- Inflammatory Bowel Diseases
- Pandemics
- Pneumonia, Viral